ID26137A - Komposisi farmasi baru dari uridin trifosfat - Google Patents

Komposisi farmasi baru dari uridin trifosfat

Info

Publication number
ID26137A
ID26137A IDW20001428A ID20001428A ID26137A ID 26137 A ID26137 A ID 26137A ID W20001428 A IDW20001428 A ID W20001428A ID 20001428 A ID20001428 A ID 20001428A ID 26137 A ID26137 A ID 26137A
Authority
ID
Indonesia
Prior art keywords
trifosphate
uridin
pharmaceutical composition
new pharmaceutical
new
Prior art date
Application number
IDW20001428A
Other languages
English (en)
Inventor
Karol K Lacroix
Christy L Shaffer
Karla M Jacobus
Janet L Rideout
David J Drutz
Richard M Evans
Pendergast William
Original Assignee
Inspire Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inspire Pharmaceuticals Inc filed Critical Inspire Pharmaceuticals Inc
Publication of ID26137A publication Critical patent/ID26137A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20001428A 1997-12-23 1998-12-23 Komposisi farmasi baru dari uridin trifosfat ID26137A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/996,740 US5968913A (en) 1996-07-03 1997-12-23 Pharmaceutical compositions of uridine triphosphate

Publications (1)

Publication Number Publication Date
ID26137A true ID26137A (id) 2000-11-23

Family

ID=25543248

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001428A ID26137A (id) 1997-12-23 1998-12-23 Komposisi farmasi baru dari uridin trifosfat

Country Status (17)

Country Link
US (1) US5968913A (id)
EP (1) EP1041969B1 (id)
JP (1) JP2001526208A (id)
KR (1) KR20010033310A (id)
CN (1) CN1143672C (id)
AR (1) AR014176A1 (id)
AT (1) ATE235225T1 (id)
AU (1) AU747350B2 (id)
BR (1) BR9814426A (id)
CA (1) CA2316018A1 (id)
DE (1) DE69812708T2 (id)
ID (1) ID26137A (id)
IL (1) IL136895A0 (id)
NO (1) NO20003246L (id)
NZ (1) NZ505821A (id)
WO (1) WO1999032085A2 (id)
ZA (1) ZA9811833B (id)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319908B1 (en) 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en) 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
TW593331B (en) 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6872710B2 (en) * 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
CA2295515C (en) 1997-07-25 2006-03-14 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US6327215B1 (en) * 2000-09-28 2001-12-04 Vanguard International Semiconductor Corporation Local bit switch decode circuit and method
AR034635A1 (es) 2001-06-25 2004-03-03 Inspire Pharmaceuticals Inc Lubricacion de las articulaciones con agonistas del receptor purinergico p2y
WO2003039473A2 (en) * 2001-11-06 2003-05-15 Inspire Pharmaceuticals, Inc. Method for treating or preventing inflammatory diseases
CN1700894A (zh) * 2002-10-18 2005-11-23 莫利化学医药公司 使用羊毛硫抗生素治疗干眼病的方法
EP1750740A4 (en) * 2004-05-06 2009-06-10 Molichem Medicines Inc TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING COMPOSITIONS CONTAINING LANTIBIOTICS
US7479481B2 (en) * 2004-05-06 2009-01-20 Molichem Medicines, Inc. Treatment of ocular diseases and disorders using lantibiotic compositions
US7368439B2 (en) * 2005-06-15 2008-05-06 Bar - Ilan University Dinucleoside poly(borano)phosphate derivatives and uses thereof
US20120077778A1 (en) * 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP2556832B1 (en) 2011-08-12 2017-07-19 Universitätsklinikum Freiburg Uridine and uridine analogues for use in the treatment of chronic obstructive pulmonary disease
US9034442B2 (en) * 2012-11-30 2015-05-19 Corning Incorporated Strengthened borosilicate glass containers with improved damage tolerance
US10117806B2 (en) * 2012-11-30 2018-11-06 Corning Incorporated Strengthened glass containers resistant to delamination and damage

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB916309A (en) * 1959-12-14 1963-01-23 Ile Auguil Soc Civ Improvements in and relating to new therapeutic preparation for use as a muscular and nervous stimulant
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
GB9027968D0 (en) * 1990-12-22 1991-02-13 Fisons Plc Method of treatment
US5164740A (en) * 1991-04-24 1992-11-17 Yehuda Ivri High frequency printing mechanism
EP0517573A1 (fr) * 1991-06-05 1992-12-09 Synthelabo Compositions pharmaceutiques pour le traitement des affections des voies respiratoires
FR2677250B1 (fr) * 1991-06-05 1995-01-20 Synthelabo Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
EP0615470B1 (en) * 1991-12-04 1995-12-13 The Technology Partnership Public Limited Company Fluid droplet production apparatus and method
US5547131A (en) * 1992-12-04 1996-08-20 Bespak Plc Dispensing device with spray nozzle and driven piston
US5497763A (en) * 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres
US5628984A (en) * 1995-07-31 1997-05-13 University Of North Carolina At Chapel Hill Method of detecting lung disease
US6423694B1 (en) * 1996-02-21 2002-07-23 Inspire Pharmaceuticals, Inc. Method of treating otitis media with uridine triphosphates and related compounds
ATE335492T1 (de) * 1996-03-27 2006-09-15 Inspire Pharmaceuticals Inc Verfahren zur behandlung der ziliardyskinesie mit uridintriphosphaten und verwandten verbindungen
US5962432A (en) * 1996-07-03 1999-10-05 Inspire Pharmaceuticals, Inc. Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate
US5789391A (en) * 1996-07-03 1998-08-04 Inspire Pharmaceuticals, Inc. Method of treating sinusitis with uridine triphosphates and related compounds
US5763447C1 (en) * 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
US6159952A (en) * 1996-11-07 2000-12-12 Inspire Pharmaceuticals, Inc. Method of treating bronchitis with uridine triphosphate and related compounds

Also Published As

Publication number Publication date
NZ505821A (en) 2002-09-27
ATE235225T1 (de) 2003-04-15
AU2092299A (en) 1999-07-12
IL136895A0 (en) 2001-06-14
CN1143672C (zh) 2004-03-31
US5968913A (en) 1999-10-19
WO1999032085A3 (en) 1999-09-02
BR9814426A (pt) 2001-10-23
NO20003246L (no) 2000-08-23
CN1284861A (zh) 2001-02-21
DE69812708T2 (de) 2004-01-29
KR20010033310A (ko) 2001-04-25
CA2316018A1 (en) 1999-07-01
JP2001526208A (ja) 2001-12-18
NO20003246D0 (no) 2000-06-21
DE69812708D1 (de) 2003-04-30
WO1999032085A2 (en) 1999-07-01
ZA9811833B (en) 1999-07-20
EP1041969B1 (en) 2003-03-26
EP1041969A2 (en) 2000-10-11
AR014176A1 (es) 2001-02-07
AU747350B2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
ID29306A (id) Bentuk baru s-omeprazola
PT1066027E (pt) Composicao farmaceutica de topiramato
ID16420A (id) Komposisi farmasi baru dengan efek anastesia
ID26137A (id) Komposisi farmasi baru dari uridin trifosfat
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
IS5245A (is) Lyfjablanda úr ómeprasól
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
ID29994A (id) Komposisi farmasi untuk melawan ccr5 terdiri dari turunan anilida
ID27040A (id) Bentuk sediaan dengan pelepasan berpulsa dari bahan farmasi oral
PT907364E (pt) Composicao farmaceutica de libertacao sustida
ID15880A (id) Bentuk baru heteroaril oksazolidinon-oksazolidinon
IS5665A (is) Lyfjafræðileg þrýstiúða samsetning
DK0920302T3 (da) Farmaceutisk aerosolsammensætning
ID27996A (id) Polimorf dari suatu bahan farmasi
ID21525A (id) Komposisi bedak baru
ID24828A (id) Komposisi-komposisi farmasi dari tizoksianida dan nitazoksanida
ID24716A (id) Formulasi baru
ID29294A (id) Komposisi farmasi
FI973229A0 (fi) Uusi farmaseuttinen koostumus
MA26531A1 (fr) Composition pharmaceutique
ID25857A (id) Komposisi farmasi
ID23885A (id) Bentuk-bentuk polimorf baru dari cypamfylline
ID27096A (id) Komposisi farmasi yang baru
ID18698A (id) Komposisi farmasi
ID24191A (id) Komposisi baru